Dow Down 0.36% Nasdaq Down 0.53%

More On ORGS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Orgenesis Inc. (ORGS)

-Other OTC
0.75 Up 0.15(24.98%) Sep 12, 3:56PM EDT
Prev Close:0.60
Open:0.75
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:-7.27
Next Earnings Date:N/A
Day's Range:0.70 - 0.75
52wk Range:0.34 - 1.00
Volume:67,325
Avg Vol (3m):7,070
Market Cap:41.29M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ORGS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orgenesis Inc., a development stage company, is engaged in research and development in the biotechnology field in Israel. It intends to develop a technology for regeneration of functional insulin-producing cells thus enabling normal glucose regula... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback